Skip to content
InMed-logo-01
  • Manufacturing
    • Cannabinoid Manufacturing Expertise
    • IntegraSyn™ Cannabinoid Manufacturing
    • BayMedica Cannabinoid Biosynthesis
  • Pharmaceutical
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • Novel Cannabinoid Analogs
    • Cannabinoids in Development
  • Products
    • Cannabidivarin (CBDV)
    • Tetrahydrocannabivarin (THCV)
    • Cannabichromene (CBC)
    • Cannabicitran (CBT)
  • Investor
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM
    • Filings
    • Presentations
    • Media
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Partners and Collaborators
    • Events Calendar
    • Careers
    • Contact
  • Learn
    • What is Cannabinol (CBN)?
    • What is Epidermolysis Bullosa (EB)?
    • What is Glaucoma?
    • Cannabinoid Manufacturing Economics 101
    • GMP Manufacturing Standards by Product Type
    • Cannabis Treatments for Glaucoma
    • Cannabinoid Science
    • Articles and Videos
Menu
  • Manufacturing
    • Cannabinoid Manufacturing Expertise
    • IntegraSyn™ Cannabinoid Manufacturing
    • BayMedica Cannabinoid Biosynthesis
  • Pharmaceutical
    • INM-755 for Epidermolysis Bullosa
    • INM-088 for Glaucoma
    • Novel Cannabinoid Analogs
    • Cannabinoids in Development
  • Products
    • Cannabidivarin (CBDV)
    • Tetrahydrocannabivarin (THCV)
    • Cannabichromene (CBC)
    • Cannabicitran (CBT)
  • Investor
    • News Releases
    • Events
    • Stock Information
    • Corporate Governance
    • Financials & AGM
    • Filings
    • Presentations
    • Media
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Partners and Collaborators
    • Events Calendar
    • Careers
    • Contact
  • Learn
    • What is Cannabinol (CBN)?
    • What is Epidermolysis Bullosa (EB)?
    • What is Glaucoma?
    • Cannabinoid Manufacturing Economics 101
    • GMP Manufacturing Standards by Product Type
    • Cannabis Treatments for Glaucoma
    • Cannabinoid Science
    • Articles and Videos
NASDAQ_Logo

Prodiol® CBT (Cannabicitran)

Cannabicitran (CBT) for the Health and Wellness Sector

InMed’s subsidiary, BayMedica, has the ultra-rare, minor cannabinoid cannabicitran (CBT) available wholesale as a raw ingredient for a variety of consumer health and wellness products, such as cosmetics, nutraceuticals, supplements and animal health.

Interested in purchasing wholesale CBT for your health and wellness products? You can initiate an order by emailing [email protected].

What is Cannabicitran (CBT)?

cbt

Cannabicitran (CBT) is one of the estimated 140+ rare cannabinoids found in the cannabis plant and is recognized as a non-intoxicating cannabinoid. CBT was discovered and isolated from Lebanese Cannabis sativa in 1974. CBT is an ultra-rare cannabinoid and there have been a few in vivo and in vitro studies completed.

Learn more about Baymedica Products

Pure and consistent cannabicitran you can trust

We know rare cannabinoids in depth. Our cannabinoid knowledge and expertise ensure you get consistent high quality and purity each and every time. Very few can produce rare cannabinoids at large commercial scale. Our CBT is produced to greater than 95% purity via a proprietary process. BayMedica’s cannabinoids are GMP level, lab tested and certified. Like all of our minor cannabinoids, Prodiol​™ CBT can be combined in precise ratios for unique health and wellness products.

Nature’s Twin – Bioidentical Cannabinoids for Your Health and Wellness Products

BayMedica has been able to reproduce rare cannabinoids that are bioidentical to those found in the plant through a clean, consistent and reliable method. Now we are bringing them to commercial scale as raw ingredients for your health and wellness products. We have large scale batches of cannabidivarin (CBDV), cannabichromene (CBC) and cannabicitran (CBT) available wholesale to health and wellness product makers. Our next production of rare cannabinoids to be released soon is tetrahydrocannabivarin (THCV).

INM-088

A cannabinol (CBN) formulation in preclinical development for the treatment of glaucoma
Learn More

IntegraSyn™

InMed’s flexible, integrated cannabinoid manufacturing system to efficiently produce pharmaceutical-grade, bio-identical cannabinoids.
Learn More
InMed-logo-mono
#310 – 815 West Hastings St.
Vancouver, BC, Canada
V6C 1B4

Manufacturing

  • Cannabinoid Manufacturing Expertise
  • IntegraSyn™ Cannabinoid Manufacturing
  • BayMedica Cannabinoid Biosynthesis

Pharmaceutical

  • INM-755 for Epidermolysis Bullosa
  • INM-088 for Glaucoma
  • Novel Cannabinoid Analogs
  • Cannabinoids in Development

Investor

  • News
  • Events
  • Stock Information
  • Corporate Governance
  • Financials & AGM
  • Filings
  • Presentations
  • Media

Products

  • Cannabidivarin (CBDV)
  • Tetrahydrocannabivarin (THCV)
  • Cannabichromene (CBC)
  • Cannabicitran (CBT)

About

  • Management
  • Board of Directors
  • Scientific Advisory Board
  • Partners and Collaborators
  • Events Calendar
  • Careers
  • Contact

Learn

  • What is Cannabinol (CBN)?
  • What is Epidermolysis Bullosa (EB)?
  • What is Glaucoma?
  • Cannabinoid Manufacturing Economics 101
  • GMP Manufacturing Standards by Product Type
  • Cannabinoids for Glaucoma
  • Cannabinoid Science
  • Articles and Videos

© Copyright 2022 InMed Pharmaceuticals Inc.

  • Privacy Policy
  • Terms of Use
  • Legal Disclaimer
  • Find Us On:
Subscribe

Sign up to receive emails from InMed Pharmaceuticals

Name*
Consent